LFCR · NASDAQ
Lifecore Biomedical (LFCR) Stock Price & Fundamentals
Lifecore Biomedical (LFCR) closed at $1,247.07 on Oct 9, 2026, up 0.47% from the previous close of $1,241.18.
Share price, past year
1Y +65.47%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $1,247.07 |
| Sep 30, 2026 | $1,256.73 |
| Aug 31, 2026 | $1,156.86 |
| Jul 31, 2026 | $1,120.28 |
| Jun 30, 2026 | $1,081.78 |
| May 29, 2026 | $1,017.12 |
| Apr 30, 2026 | $987.53 |
| Mar 31, 2026 | $965.34 |
| Feb 27, 2026 | $929.76 |
| Jan 30, 2026 | $902.81 |
| Dec 31, 2025 | $855.19 |
| Nov 28, 2025 | $883.06 |
| Oct 31, 2025 | $856.26 |
Key statistics
- Market cap
- $46.74B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 37.5M
- Dividend yield
- —
- 52-week range
- $753.65 – $1,262.63
Lifecore Biomedical's market cap is $46.74B, based on a share price of $1,247.07 and 37.5M shares outstanding as of Mar 31, 2026.
Financials
Lifecore Biomedical reported revenue of $128.87M for fiscal 2025, up 0.47% from fiscal 2024.
Lifecore Biomedical reported a net loss of $38.72M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended May 25, 2025 | $128.87M | +0.5% | −$38.72M | −30.0% | −$1.27 | −$13.62M |
| FY2024ended May 26, 2024 | $128.26M | +24.2% | $12.01M | 9.4% | $0.33 | −$18.14M |
| FY2023ended May 28, 2023 | $103.27M | −7.2% | −$99.56M | −96.4% | −$3.32 | — |
| FY2022ended May 29, 2022 | $111.27M | +10.3% | −$116.72M | −104.9% | −$3.97 | −$48.82M |
| FY2021ended May 30, 2021 | $100.87M | −37.0% | −$32.29M | −32.0% | −$1.10 | −$2.79M |
| FY2020ended May 31, 2020 | $160.07M | −71.3% | −$38.19M | −23.9% | −$1.31 | −$29.26M |
| FY2019ended May 26, 2019 | $557.56M | +6.4% | $411.00K | 0.1% | $0.01 | −$28.71M |
| FY2018ended May 27, 2018 | $524.23M | +11.6% | $24.83M | 4.7% | $0.89 | −$13.81M |
| FY2017ended May 28, 2017 | $469.78M | −1.5% | $10.59M | 2.3% | $0.38 | $6.84M |
| FY2016ended May 29, 2016 | $476.92M | — | −$11.64M | −2.4% | −$0.43 | −$18.93M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q3 FY2026ended Mar 31, 2026 | $23.19M | −$14.98M | −$0.43 |
| Q1 FY2026ended Sep 30, 2025 | $31.11M | −$9.99M | −$0.29 |
| Q4 FY2025ended May 25, 2025 | $36.44M | −$1.15M | −$0.06 |
| Q3 FY2025ended Feb 23, 2025 | $35.15M | −$14.77M | −$0.42 |
| Q2 FY2025ended Nov 24, 2024 | $32.56M | −$6.57M | −$0.25 |
| Q1 FY2025ended Aug 25, 2024 | $24.71M | −$16.23M | −$0.53 |
| Q4 FY2024ended May 26, 2024 | $37.89M | −$7.08M | — |
| Q3 FY2024ended Feb 25, 2024 | $35.70M | $15.63M | $0.42 |
Company profile
- Name
- Lifecore Biomedical, Inc.
- Ticker
- LFCR
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 3515 Lyman Boulevard, Chaska, MN 55318
- Incorporated in
- DE
- Fiscal year ends
- May
- SEC CIK
- 0001005286
Recent SEC filings
- Sep 29, 2026
- Sep 28, 2026
- Aug 5, 2026
- Aug 5, 2026
- Jul 2, 2026
- Jun 5, 2026
- May 6, 2026
- May 6, 2026
Frequently asked questions
What is Lifecore Biomedical's stock price?
Lifecore Biomedical (LFCR) closed at $1,247.07 on Oct 9, 2026, up 0.47% from the previous close of $1,241.18.
What is Lifecore Biomedical's market cap?
Lifecore Biomedical's market cap is $46.74B, based on a share price of $1,247.07 and 37.5M shares outstanding as of Mar 31, 2026.
How much revenue does Lifecore Biomedical make?
Lifecore Biomedical reported revenue of $128.87M for fiscal 2025, up 0.47% from fiscal 2024.
Sources and methodology
Fundamentals come from Lifecore Biomedical, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures